$270 Million OxyContin Settlement Won’t Solve Oklahoma’s Opioid Crisis

2019-3-28 19:26

By CCN. com: Drug manufacturer Purdue Pharma finally settled a lawsuit with the state of Oklahoma, with the OxyContin maker agreeing to pay $270 million to fund addiction research, addiction treatment, and legal fees.

Oklahoma OxyContin Victims Experience Bittersweet Victory The company was sued because of deceptive marketing tactics that downplayed the addictive nature of their drug, OxyContin, a strong opioid responsible for the death of over 200,000 Americans. Attorney General Mike Hunter filed this suit two years ago, initially seeking $20 billion in damages. Even though Hunter and the state of Oklahoma successfully recovered $270 million from Purdue Pharma, the

The post $270 Million OxyContin Settlement Won’t Solve Oklahoma’s Opioid Crisis appeared first on CCN

.

Similar to Notcoin - TapSwap on Solana Airdrops In 2024

origin »

Maker (MKR) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0 - H: $3772.91
Капитализация $0 Rank 99999
Цена в час новости $ 736.7 (-100%)

oklahoma oxycontin million 270 opioid state addiction

Источник: ccn.com

Партнеры Currencies.ru

Реклама на Currencies.ru

Самое свежее на Currencies.ru

OxyContin-Stained Sackler Fortune Too Toxic for This Woke Hedge Fund

Under fire for fueling the opioid crisis, the billionaire family that controls OxyContin maker Purdue Pharma LP has been booted from a large hedge fund, the Wall Street Journal reports. Hildene Capital Dumps Family Behind OxyContin Fortune Last year, Hildene Capital Management, which manages some $10 billion in client assets, notified Sackler family investment entities that it would no longer handle their money.

Deadly Opioid Crisis Is The US Government’s Fault, Not Big Pharma’s

Suing Purdue Pharma for the opioid abuse epidemic is like suing McDonald’s for your obesity or diabetes. Reuters had the exclusive story about the opioid crisis Monday: “OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the United States, people familiar with the matter said on Monday.